Skip to main content
Health Economics Review logoLink to Health Economics Review
. 2020 Apr 17;10:8. doi: 10.1186/s13561-020-00265-0

Correction to: The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain

M Chris Runken 1, Paolo Caraceni 2, Javier Fernandez 3,4, Alexander Zipprich 5, Rashad Carlton 6,, Martin Bunke 7
PMCID: PMC7165406  PMID: 32303863

Correction to: Health Economics Review (2019) 9:22

https://doi.org/10.1186/s13561-019-0237-7

Following publication of the original article [1], the authors reported that one of the numbers within Fig. 6 contains a mistake.

The correct Fig. 6 is shown below.

Fig. 6.

Fig. 6

Expected cost of treatment of the different strategies for SBP

Footnotes

The original article can be found online at 10.1186/s13561-019-0237-7

Reference

  • 1.Runken, et al. The cost-effectiveness of albumin in the treatment of decompensated cirrhosis in Germany, Italy, and Spain. Health Economics Review. 2019;9:22. doi: 10.1186/s13561-019-0237-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Health Economics Review are provided here courtesy of Springer-Verlag

RESOURCES